VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 183 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29 | -80.1% | 6,768 | -69.4% | 0.00% | – |
| Q2 2023 | $146 | -70.6% | 22,100 | -69.8% | 0.00% | -100.0% |
| Q1 2023 | $497 | -8.1% | 73,200 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $541 | -99.9% | 73,200 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $723,000 | -48.5% | 73,200 | -43.2% | 0.00% | -33.3% |
| Q2 2022 | $1,404,000 | -94.5% | 128,800 | -94.3% | 0.00% | -93.6% |
| Q1 2022 | $25,620,000 | -27.8% | 2,265,237 | +0.2% | 0.05% | -25.4% |
| Q4 2021 | $35,467,000 | -2.8% | 2,260,482 | +6.2% | 0.06% | -4.5% |
| Q3 2021 | $36,492,000 | -8.3% | 2,129,097 | +15.1% | 0.07% | -2.9% |
| Q2 2021 | $39,794,000 | +100.9% | 1,850,048 | +40.3% | 0.07% | +100.0% |
| Q1 2021 | $19,811,000 | +295.4% | 1,318,982 | +245.8% | 0.03% | +277.8% |
| Q4 2020 | $5,011,000 | – | 381,417 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |